drugset
drugset / Trial / NCT06419582

BHV-7000 Acute Treatment of Bipolar Mania

NCT06419582 ↗

Phase 2/3 Completed 274 enrolled Biohaven Therapeutics Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.

Timeline

Start
2024-05-28
Primary completion
2025-01-15
Completion
2025-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BHV-7000 Unknown 75 mg —

Indications

bipolar disorder